Avallano has introduced ProtocolCopilot, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.

ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols. By providing a chatbot interface, it ensures that users can effortlessly access crucial protocol information without the need to navigate through cumbersome documents.

One of the key features of ProtocolCopilot is its AI-powered information retrieval. The tool utilizes sophisticated AI to ingest, process, and respond to specific questions about a protocol, eliminating the need for manual searches and hyperlink navigation. This significantly enhances usability, delivering answers directly to users' questions and enabling them to bypass the time-consuming process of scanning lengthy documents.

Additionally, ProtocolCopilot acts as a memory refresher, facilitating quick reference checks and aiding users in recalling specific protocol procedures effortlessly. It also provides a user-friendly learning experience, offering an engaging and intuitive platform for users to familiarize themselves with protocol details, thereby enhancing the overall user experience.

Compliance support is another crucial feature of ProtocolCopilot. The tool promotes adherence to proper procedures, inclusions/exclusions, and drug-related queries, which is particularly beneficial under tight schedules and heavy workloads. Mobile accessibility further enhances its utility, offering a convenient, on-the-go reference solution for busy site staff juggling multiple studies.

ProtocolCopilot also offers customizable outputs, tailored to provide answers in various languages and at suitable reading levels, thus accommodating diverse user needs. The "Correct AI" assurance implements a rigorous process to ensure that responses are factual, protocol-based, and accurate.

With ProtocolCopilot, clinical research professionals can focus more on critical tasks rather than getting bogged down by extensive protocol documents. This tool is especially beneficial for site staff who are often overwhelmed by the cognitive demands of managing numerous studies simultaneously.

"We are excited to bring ProtocolCopilot to the market, offering a cutting-edge solution that not only enhances efficiency but also supports compliance and accuracy in clinical research," said Paul Della Maggiora, CEO of Avallano.

"By leveraging the power of AI, we are addressing a significant pain point in the industry and empowering research professionals with a tool that understands their needs," Maggiora added.

Avallano is seeking early partners for the testing and deployment of ProtocolCopilot. To learn more or request a demonstration, please contact Jillian Stamatis.